The replication-competent CRAd Delta 24 was provided by Dr. J. Fueyo. (The University of Texas M. D. Anderson Cancer Center, Houston, TX). This virus contains a 24-nucleotide deletion, from Ad5 bp 923 to 946 (both included), corresponding to the amino acid sequence L
122TCHEAGF
129 of the E1A protein known to be necessary for Rb protein binding [
36]. Details of the tumor-specific replication of this virus are presented elsewhere [
37,
38]. The incorporation of the RGD-4C motif, known to interact with α
v integrins, into the HI loop of the fiber knob (T
546CDCRGDCFCP
547) to enhance Delta24 CRAd infection efficiency of tumor cells was described previously [
15,
39]. The construction of Ad5/3-Delta24 CRAd, which contains the fiber knob domain replaced with its counterpart from Ad serotype 3 (Ad3) was described elsewhere [
9,
40]. The construction of Ad5/3-Delta24-based CRAd-IL24 and CRAd-ING4 vectors expressing human IL-24 [
41] or ING4 (the inhibitor of growth 4) [
42] gene, respectively, under transcriptional control of human cytomegalovirus (CMV) immediate-early promoter/enhancer incorporated in place of the deleted E3B region was described in detail recently [
43]. Non-armed control CRAd that encodes the secreted Gaussia luciferase (Gluc) from the copepod
Gaussia princeps (New England BioLabs Inc., Ipswich, MA USA) driven by CMV promoter in place of E3B region was described recently [
43]. Wild-type Ad5 was kindly provided by Dr. H Ugai (Washington University in St Louis, St Louis, MO).The replication incompetent Ad5∆E1 containing the CMV promoter-driven firefly luciferase reporter gene in place of the deleted E1A/B genes was described before [
44] and propagated using 911 cells. All CRAd vectors and wild type Ad5 were propagated using A549 cells, purified by centrifugation on CsCl gradients according to standard protocol, and dialyzed against phosphate-buffered saline (PBS) (8 mM Na
2HPO
4, 2 mM KH
2PO
4 [pH 7.4], 137 mM NaCl, 2.7 mM KCl] containing 10% glycerol. The titers of physical viral particles (vp) were determined by the methods of Maizel et al. [
45]. The titers of infectious viral particles were determined by plaque assay using 911 cells as described by Mittereder et al. [
46].